Does TOFACITINIB Cause Dyspepsia? 2,264 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,264 reports of Dyspepsia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.5% of all adverse event reports for TOFACITINIB.
2,264
Reports of Dyspepsia with TOFACITINIB
1.5%
of all TOFACITINIB reports
683
Deaths
822
Hospitalizations
How Dangerous Is Dyspepsia From TOFACITINIB?
Of the 2,264 reports, 683 (30.2%) resulted in death, 822 (36.3%) required hospitalization, and 792 (35.0%) were considered life-threatening.
Is Dyspepsia Listed in the Official Label?
Yes, Dyspepsia is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dyspepsia?
ADALIMUMAB (3,586)
METHOTREXATE (2,690)
RITUXIMAB (2,289)
PREDNISONE (2,224)
APREMILAST (2,207)
ETANERCEPT (2,100)
ESOMEPRAZOLE (2,064)
TOCILIZUMAB (2,046)
LEFLUNOMIDE (1,981)
INFLIXIMAB (1,885)
Which TOFACITINIB Alternatives Have Lower Dyspepsia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN